Search

everythinglearnresearchcommunity

for

Search:↓

Targeted cancer therapies often cause skin side effects, needing dermatologist care.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

Scaffold-based drug delivery systems improve oral cancer treatment by targeting drugs directly to cancer cells, reducing side effects.

Trametinib can effectively treat severe kaposiform lymphangiomatosis when other treatments fail.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

Patients with fewer past treatments for alopecia areata respond better to baricitinib.

The consensus provides guidelines for safely stopping danazol in hereditary angioedema treatment.

Adalimumab significantly improves quality of life for patients with moderate to severe hidradenitis suppurativa.

Thalidomide with CHOP is more effective for peripheral T-cell lymphoma than CHOP alone.

Pexidartinib often causes liver issues and fatigue, especially in women.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

The treatment was effective for advanced non-Hodgkin's lymphomas.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

The supplement highlighted advancements and challenges in plastic and reconstructive surgery, including the impact of smoking, chemotherapy, and new treatments like Tafluprost for hair loss.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Radiation therapy in breast cancer patients changes gene expression related to DNA damage, fibroblast growth, and hair follicle development, which could help improve treatment for radiation-induced fibrosis.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

XMU-MP-1 stops cell growth in a human mini-organ and reduces the effectiveness of the chemotherapy drug paclitaxel.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Both vaginal testosterone cream and Estring effectively manage vaginal dryness in women with early-stage breast cancer on aromatase inhibitors.

Topical finasteride with EGCG or TA improves drug release and dermal uptake, potentially treating hair loss effectively.

Exercise may help reduce treatment side effects and improve survival in metastatic colorectal cancer.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Nano-Pulse Stimulation™ Therapy is more effective and less damaging than cryoablation for treating melanoma tumors in mice.

Tofacitinib might be used to treat hair loss.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Tridax procumbens extracts may help treat cancer due to their strong anticancer and antioxidant properties.

The document concluded that there were no effective ways to prevent hair loss from chemotherapy but treatments were being explored.

GC10/DOX hydrogel shows promise as an effective thyroid cancer treatment.